Govt panel recommends against allowing SII to conduct trial of Covovax on children
Published By : Prameya News Bureau | July 01, 2021 IST
Share
New Delhi, July 1: An expert panel of the country's central drug authority has recommended against granting permission to the Serum Institute of India (SII) to conduct the phase 2/3 trial of COVID-19 vaccine Covovax on children aged 2 to 17 years. According to the sources, the Central Drugs Standard Control Organisation (CDSCO) has not approved SII's request to allow clinical trials of its second Covid19 vaccine in children. The SII applied to the Drugs Controller General of India (DCGI) on Monday seeking permission for conducting a trial of Covovax on 920 children, 460 each in the 12-17 and 2-11 age groups, at 10 sites. The Subject Expert Committee (SEC) on COVID-19 of CDSCO, which deliberated on the application, noted that the vaccine has not been approved in any country, a source said. It also recommended that the Pune-based company should submit the safety and immunogenicity data (of Covovax) from the ongoing clinical trial in adults for considering the conduct of a clinical trial in children, the source said.
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
Lok Sabha polls: NCP(SP)’s manifesto promises Rs 1 lakh/year dole to poor women & jobless youth
JDU youth leader shot dead in Bihar’s Patna
Lok Sabha polls: PM Modi to campaign in MP, UP today
Karnataka's Election Commission plans 1,832 special polling booths for inclusive voting
Bridge connecting to Manipur damaged by IED blasts
BRS chief KCR starts 17-day bus yatra to boost party campaign ahead of polls
All three units of EVMs have their own microcontroller: SC informed
India to become one of biggest semiconductor hubs in next 5 years: Vaishnaw
PM Modi advocates for resilient infrastructure at 39-nation meet on natural disasters
Supreme Court to issue directions on mandatory VVPAT verification
PM Modi to address public meetings in Chhattisgarh, MP today
DRDO develops India's lightest bulletproof jacket
Lok Sabha polls: NDA will sweep all 28 seats in K'taka, says Amit Shah
India carries out successful launch of medium-range ballistic missile's new version
Fire at Bandhwari landfill site raises concerns
EcoR to run 10 Summer Special trains in Odisha, Know details.....
Surat Congress leader Nilesh Kumbhani 'vanishes' amid election controversy
BJP dividing people in name of religion: Sharmila
More than 5 grams of artificial sweetener saccharin a day can be fatal: Doctors
PayU gets RBI's in-principle nod to operate as payments aggregator